| |
|
|
|
World Trade Group, Cologne, Germany
5th - 6th December 2006
The 6th Annual World Drug Discovery & Development Summit brings together over 300 leading pharmaceutical and
biotech professionals to discuss the key scientific and strategic challenges faced by the industry today. WDD 2006 focuses on how companies can reduce attrition and improve productivity through enabling and predictive
technologies; supported by industry led case studies from leading pharmaceutical companies.
|
|
|
|
|
|
|
|
Organized by:
|
|
World Trade Group |
|
|
Invited Speakers:
|
|
Dr Hanno Wild, Senior Vice President Discovery Europe, Pharma Global Drug Discovery, Bayer HealthCare AG
Prof. Ian Wilson, Senior Principal Scientist, AstraZeneca
Dr Graham Dixon, Senior Vice President, Drug Discovery, Galapagos NV
Dr Frank Sams-Dodd, Vice President, Preclinical Development, Bionomics
Peter O’ Brien, Head of Discovery Toxicology Biomarkers, Pfizer
Dr Jeffrey Waring, Group Leader, Toxiocogenomics, Abbott Laboratories
Dr Irina Antonijevic, Director, Translational Research , Lundbeck Research
Dr Frank Büttner, Department of Lead Discovery, Boehringer-Ingelheim
Dr Dan Burns, Senior Vice President, Pharmacogenetics, GlaxoSmithKline
Peter O’ Brien, Head of Discovery Toxicology Biomarkers, Pfizer
Dr Jan ter Meulen, Executive Director, Infectious Diseases, Crucell
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
none
|
|
|
|
|
|
|
|
Registration:
|
|
www.wddsummit.com
+ 44 (0)20 7940 5547
|
|
|
E-mail:
|
|
lisa.wulf@worldtradeco.com
|
|
|
|
|
|
|
|
|